Castlight Health, Inc. CSLT
We take great care to ensure that the data presented and summarized in this overview for CASTLIGHT HEALTH, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CSLT
Top Purchases
Top Sells
About CSLT
Insider Transactions at CSLT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2022
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
126,058
-100.0%
|
-
|
|
Feb 17
2022
|
Seth B. Cohen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
208,712
-100.0%
|
-
|
|
Feb 17
2022
|
Michael L. Eberhard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
425,809
-100.0%
|
-
|
|
Feb 17
2022
|
David A Ebersman Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
630,803
-100.0%
|
-
|
|
Feb 17
2022
|
David A Ebersman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,354
-100.0%
|
-
|
|
Feb 17
2022
|
Ed Park Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
David B Singer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
Venrock Associates V LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,255,264
-100.0%
|
-
|
|
Feb 17
2022
|
Bryan E Roberts Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,255,264
-100.0%
|
-
|
|
Feb 17
2022
|
Bryan E Roberts Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
Kenny Van Zant Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
661,794
-100.0%
|
-
|
|
Feb 17
2022
|
Judith K. Verhave Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
351,516
-100.0%
|
-
|
|
Feb 17
2022
|
William Bondurant Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
355,661
-100.0%
|
-
|
|
Feb 17
2022
|
Maeve O'Meara Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,625,989
-100.0%
|
-
|
|
Nov 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,114
-5.85%
|
$22,114
$1.77 P/Share
|
|
Nov 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,629
-5.71%
|
$7,629
$1.78 P/Share
|
|
Nov 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
99,009
-5.74%
|
$99,009
$1.77 P/Share
|
|
Nov 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,574
+2.68%
|
-
|
|
Nov 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,626
+3.16%
|
-
|
|
Nov 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,290
+1.84%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders